Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (49)

« Back to Publications

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial

Erameh C. et al, (2026), Nature Medicine

Post-discharge sequelae of Lassa fever survivors in Nigeria: an analysis of the LASCOPE prospective cohort.

Guichard E. et al, (2026), The Lancet. Infectious diseases

Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria.

Erameh C. et al, (2025), Journal of infection and public health, 18

Establishment of a Lassa Fever Specimen Biobank in Nigeria.

Chi HF. et al, (2025), The American journal of tropical medicine and hygiene, 113, 382 - 386

Corrigendum to “Clinical manifestations and outcomes of human mpox infection from 1970 to 2023: A systematic literature review” [Clin. Infect. Pract. 24 (2024) 100397] (Clinical Infection in Practice (2024) 24, (S2590170224000578), (10.1016/j.clinpr.2024.100397))

Abejegah C. et al, (2025), Clinical Infection in Practice, 26

Evaluation of the diagnostic accuracy of the ReLASV Pan-Lassa Antigen Rapid Test for Lassa Fever in Nigeria.

Chi HF. et al, (2025), PLOS global public health, 5

Impact of seasonal change on virus-rodent dynamics in Nigeria's Edo-Ondo hotspot for Lassa fever

Oyeyiola A. et al, (2025), Current Research in Parasitology and Vector Borne Diseases, 7

Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)

Duvignaud A. et al, (2024), Journal of the Pediatric Infectious Diseases Society, 13, 513 - 522

Clinical manifestations and outcomes of human mpox infection from 1970 to 2023: A systematic literature review

Abejegah C. et al, (2024), Clinical Infection in Practice, 24, 100397 - 100397

Immunological insights into COVID-19 in Southern Nigeria

Ugwu CA. et al, (2024), Frontiers in Immunology, 15

Circulation of Lassa virus across the endemic Edo-Ondo axis, Nigeria, with cross-species transmission between multimammate mice

Adesina AS. et al, (2023), Emerging Microbes & Infections, 12

Train-the-trainers intervention for national capacity building in infection prevention and control for COVID-19 in Nigeria

Shehu NY. et al, (2023), Heliyon, 9, e21978 - e21978

Knowledge, Perception, and Uptake of Mandatory COVID-19 Vaccination among Nigerian Civil Servants: Implications for Evidence-Based Policies

Awunor NS. et al, (2023), Journal of Community Medicine and Primary Health Care, 35, 89 - 102

Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria

Oguzie JU. et al, (2023), Nature Communications, 14

The Unusual Finding of Peripheral Lymphadenopathy Among Confirmed Lassa Fever Patients in Nigeria

Owhin SO. et al, (2023), Future Science OA, 9

Load More